UBS Group’s Concordia International Corp. Common Stock CXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,190
Closed -$3K 8535
2018
Q1
$3K Sell
6,190
-20,594
-77% -$13.5K ﹤0.01% 7496
2017
Q4
$18K Buy
+26,784
New +$18.4K ﹤0.01% 6651
2017
Q2
Sell
-3,496
Closed -$6K 8254
2017
Q1
$6K Sell
3,496
-33,924
-91% -$73.1K ﹤0.01% 6949
2016
Q4
$79K Buy
37,420
+36,600
+4,463% +$112K ﹤0.01% 5464
2016
Q3
$4K Sell
820
-221
-21% -$2.77K ﹤0.01% 7237
2016
Q2
$23K Buy
1,041
+230
+28% +$6.06K ﹤0.01% 6201
2016
Q1
$21K Sell
811
-383
-32% -$11.4K ﹤0.01% 6182
2015
Q4
$48K Buy
1,194
+494
+71% +$17.4K ﹤0.01% 5865
2015
Q3
$30K Sell
700
-2,069
-75% -$153K ﹤0.01% 6301
2015
Q2
$200K Buy
+2,769
New +$200K ﹤0.01% 4873

Other funds holding CXRX

UBS Group's CXRX Position: Q2 2018 in Review

UBS Group sold out of Concordia International Corp. Common Stock (CXRX) in Q2 2018, closing a stake of 6,190 shares — an estimated $3K sold.

UBS Group first reported a position in CXRX in Q2 2015 and held it in 10 quarters. The position peaked at $200K in Q2 2015. 4 funds tracked by Wall St. Rank hold CXRX as of Q2 2018.

  • UBS Group reported no remaining Concordia International Corp. Common Stock position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 6,190 Concordia International Corp. Common Stock shares in Q2 2018, an estimated $3K.
  • UBS Group first reported a position in Concordia International Corp. Common Stock in Q2 2015 and held it in 10 quarters.
  • UBS Group's Concordia International Corp. Common Stock position peaked at $200K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Concordia International Corp. Common Stock as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.